This article provides expert guidance on the management of pruritus symptoms in patients receiving obeticholic acid (OCA) as treatment for primary biliary cholangitis (PBC). PBC is a chronic, autoimmune cholestatic liver disease that affects intrahepatic bile ducts. If not adequately treated, PBC can lead to cholestasis and end-stage liver disease, which may require transplant. Timely treatment is therefore vital to patient health. Pruritus is a common symptom in patients with PBC. Additionally, the use of OCA to treat PBC can contribute to increased pruritus severity in some patients, adding to patient discomfort, decreasing patient quality of life (QoL), and potentially affecting patient adherence to OCA treatment.
Chandler, AZ, April 27, 2024 / Today, we remember and honor a truly remarkable individual and…
AZ Liver's own Vicki McIntyre, DNP, FNP was featured on the popular Tucson morning show…
As part of its mission to educate the community about liver health, AZ Liver Health…
In this review we critically assess the literature to evaluate the level of risk posed…
Abstract: Hepatitis C virus (HCV) infects more than 185 million individuals worldwide. Twenty percent of…
The interferon (IFN)–free regimen of sofosbuvir and ribavirin for 24 weeks was recently approved to…